Ralph A. Highshaw, M.D.

I read an article the other day. It was another discussion on physician utilization. Utilization has to do with efficient use of medical tests and facilities by the physician. Over utilization by certain physicians has been tied to excess use of federal funds for patient care, such as medicare.

The question is: Are positive surgical margins more common after treatment of prostate cancer with Robotic-Assisted Laparoscopic Prostatectomy versus Radical Retropubic Prostatectomy?

Positive surgical margins are the margins of the specimen, in this case the prostate, that are inked by the doctor called a pathologist.

A positive surgical margin or multiple positive margins implies a higher likelihood of spread of the cancer being found outside of the prostate either at the time of removal or in the future. In other words, the cancer was not contained at the time of removal. Hence, answering the question: “Are positive surgical margins more common after treatment of prostate cancer with Robotic-Assisted Laparoscopic Prostatectomy versus Radical Retropubic Prostatectomy?” is valid.

Dr. Saxon wrote an article entitled “How Wireless Technology Will Change Global Health” in September 2010.

Her article is very provocative because in the article she outlines uses for iPhones and iPads which could change the way we treat patients. She describes using the iPhone to monitor a heart patient’s blood pressure, pulse, etc. through streaming on these devices. This would allow doctors to have a more precise and live update on his or her patient so as to make change immediately as necessary.

1) What is urology?

Urology (not neurology) is the study of medicine that deals with handling illnesses related to the kidneys, bladder, prostate (in men), urethra (voiding tube) and ureters (the tubes that drain the kidney into the bladder). Urology deals with male and female issues in these areas mentioned above.

2) What is a bladder spasm?

Bladder spasms are contractions of the bladder that can result in urgency (inability to hold urine), frequency and pain felt after voiding in the bladder or abdomen, or sometimes at the tip of the penis or near the rectum.

A vasectomy is a ligation (cutting, tying off with suture, disruption) of the flow of sperm through the vas deferens. The vas deferens is a tubular structure which is connected to another tubular structure called the epididymis, which is connected to the testicle, which produces the sperm.

Kidney stones or nephrolithiasis can be a cause of severe pain. Typical symptoms include back pain on the side of the stone that may be associated with nausea, vomitting, fever, and chills. Stones that are found in the ureter, the tube connecting the kidney to the bladder (which drains the kidney), often get stuck and obstruct the flow of urine. This leads to severe back pain known as flank pain or renal colic. It can lead to an infection of the kidney as well known as pyeloneprhitis.

In one of earlier blogs, I discussed some of the traditional treatments for prostate cancer. Some of these treatments are radical retropubic prostatectomy, robotic prostatectomy, laparoscopic prostatectomy, cryoablation, radiation treatment (example, IMRT and Brachytherapy), androgen deprivation, and active surveillance. I want to discuss a new modality of treatment for prostate cancer called HIFU or High Intensity focused Ultrasound Therapy.

HIFU was first discovered in the 1950′s and improved as a use for treatment of prostate cancer over the last few decades. HIFU is minimally invasive. It kills prostate cancer cells by thermal ablation. Surgery and radiation is not used to kill the prostate cancer cells. There is no blood loss and no incision! Patients are typically sent home the same day of treatment, and back to regular activity quicker than after surgical management

Provenge is now approved by the FDA for use in patients with metastatic, hormone refractory prostate cancer. These are patients who do not respond to androgen deprivation therapy. Androgen deprivation therapy involves lowering testosterone levels in the body to below castration levels. This is done because prostate cancer cells feed by testosterone. In a clinical trial of 512 patients across multiple institutions, Provenge was shown to improve the overall survival of prostate cancer patients by 4.1 months.

Benign Prostatic Hyperplasia othewise known as BPH or an enlarged prostate is common to many men. Fifty-percent of men ages 5o and above may have symptoms. The chance of being symptomatic occurs in a higher percentage each decade after age 50.

The symptoms include frequency, urgency, nocturia ( getting up at night to urinate), incomplete emptying, hesistancy, or at worst urinary retention. treatment is recommended if your life is adversely affected by any one or more of these symptoms.